Advanced BioHealing

About:

Advanced BioHealing develops regenerative medicine solutions and commercializes cell-based and tissue-engineered products.

Website: http://abh.com

Top Investors: Safeguard Scientifics, Canaan Partners, Red Abbey Venture Partners, Wheatley Partners, Channel Medical Partners

Description:

Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

Total Funding Amount:

$34.8M

Headquarters Location:

Westport, Connecticut, United States

Founded Date:

2003-01-01

Contact Email:

alowe(AT)organo.com

Founders:

David E. Eisenbud

Number of Employees:

501-1000

Last Funding Date:

2007-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai